Abiopharma

OTC Markets Group Names Thomas Fasano Head of Broker-Dealer Sales

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Shock Top Kicks Off the World’s Biggest Summer of Soccer with Shocking Upsets

Surge Copper Announces Results of Berg Pre-Feasibility Study with After-Tax NPV8% of C$4.6 billion and 24% IRR

Lightbridge to Participate in Upcoming Investor and Nuclear Industry Events

Enhanced Group Announces $50 Million Strategic Financing Led by Enhanced Co-Founder and Chairman Christian Angermayer; Management Expects Company Fully Funded Through Profitability

Oceaneering to Participate at the 2026 J.P. Morgan Natural Resources Conference

Form 8.3

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of Director